Analysis of endocrinological examination and lymphocyte composition of the peripheral blood in patients taking anamorelin

Analysis of endocrinological examination and lymphocyte composition of the peripheral blood in patients taking anamorelin - Analysis of endocrinological examination and lymphocyte composition of the peripheral blood in patients taking anamorelin

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044653

Enrollment

Registered

2021-06-25

Start date

2021-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with cancer cachexia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with gastric cancer, pancreatic cancer, or colorectal cancer who are planned to start taking anamorelin

Exclusion criteria

Exclusion criteria: Women who are pregnant

Design outcomes

Primary

Measure	Time frame
Comparatively analyze the hormone levels and immune function before and after anamorelin administration	—

Countries

Japan

Contacts

Public ContactMasaya Iwamuro

Okayama University Hospital Department of Gastroenterology and Hepatology

iwamuromasaya@yahoo.co.jp0862357218

Outcome results